SecBot SecBot
424B4 ·Filed Mar 23, 2026

JAN

Janus Living, Inc.
NEUTRAL
Impact 5/10
Horizonimmediate Processed7mo ago SEC0001104659-26-032901
Prospectus supplement
Actionable Insight • Neutral

Monitor the company's use of proceeds from the IPO, particularly regarding potential acquisitions in the senior housing sector. The high concentration of ownership by Healthpeak (83.6% voting power) could influence corporate decisions, and investors should watch for any changes in the relationship between the company and its manager.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
JAN ▲ +7.54% at T+60d
NEUTRAL call +7.54% · α vs SPY -5.52% · entry $23.75 → $25.54
Entry = T+0 close
Mar 23, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.36%
$23.75
settled 7mo ago
T+5d
-3.62%
call -3.62% · α -0.06%
$22.89
settled 7mo ago
T+20d
+4.08%
call +4.08% · α -3.34%
$24.72
settled 6mo ago
T+60d
+7.54%
call +7.54% · α -5.52%
$25.54
settled 4mo ago

Executive Summary

Janus Living, Inc. is conducting its initial public offering (IPO) of 42 million shares of Class A-1 common stock at $20.00 per share, raising approximately $785.4 million in gross proceeds before expenses. The company, which will be externally managed by Healthpeak Investment Management, LLC, is focused exclusively on the senior housing sector with a portfolio of 34 communities. The offering is priced at a discount to the pro forma net tangible book value, resulting in immediate dilution for new investors. Proceeds will be used for general corporate purposes and potential acquisitions.

Key Facts

  • Offering 42 million shares at $20.00 per share, raising $840 million in gross proceeds
  • Healthpeak will own approximately 83.6% of voting power after the offering
  • Company will be externally managed by Healthpeak Investment Management, LLC
  • Net proceeds estimated at $760.6 million after underwriting discount and expenses
  • Proceeds will be used for acquisition opportunities and general corporate purposes
  • Dilution of $11.34 per share for new investors based on pro forma net tangible book value

Financial Impact

The company will receive approximately $785.4 million in proceeds before expenses from the sale of 42 million shares at $20.00 per share

dilutionproceedsequity

Risk Factors

  • High concentration of ownership by Healthpeak may limit influence of public shareholders
  • External management structure creates potential conflicts of interest
  • Dilution for new investors purchasing shares at the IPO price

Investment Themes

Real Estate

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001104659-26-032901
Document: 0001104659-26-032901-index-headers.html0001104659-26-032901
Document: 0001104659-26-032901-index.html0001104659-26-032901
Document: 0001104659-26-032901.txt0001104659-26-032901
6 reports for JAN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for JAN — sortable, filterable
TypeNow
Aug 11, 2026
11w ago
EFFECT
BEARISH ★ 4/10
$29.57 $31.00▼ −4.84%▼ −5.89%$27.83 (+5.87%)
Jun 3, 2026
20w ago
424B4
MIXED ★ 6/10
$24.65 $29.12▲ +18.13%▲ +19.51%$27.83 (+12.92%)
Jun 3, 2026
20w ago
EFFECT
NEUTRAL ★ 3/10
$24.65 $29.12▲ +18.13%▲ +19.13%$27.83 (+12.92%)
Mar 23, 2026
31w ago
424B4
NEUTRAL ★ 5/10
$23.75 $24.72▲ +4.08%▼ −3.34%$27.83 (+17.20%)
Mar 23, 2026
31w ago
Insider Cluster
BULLISH ★ 7/10
$23.75 $24.72▲ +4.08%▼ −3.34%$27.83 (+17.20%)
Mar 20, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$23.60 $25.17▲ +6.65%▼ −2.67%$27.83 (+17.94%)
Showing 6 of 6

US Market Status

Market Open — Closes in 3h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 23, 2026